Clinical Polyneuropathy Does Not Increase with Prediabetes or Metabolic Syndrome in the Japanese General Population

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2019 Apr 14

PMID 30980464

Citations 6

Authors

Seigo Kurisu

Hideyuki Sasaki

Shohei Kishimoto

Kazuhiro Hirayasu

Kinichi Ogawa

Shohei Matsuno

Hiroto Furuta

Mikio Arita

Keigo Naka

Kishio Nanjo

Takashi Akamizu

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: The prevalence of clinical polyneuropathies (ClinPNs) or nerve conduction abnormality (NCA) in the groups stratified by glucose tolerance, individual components of metabolic syndrome (metabolic syndrome [MetS] components: hypertension, dyslipidemia, obesity) and MetS defined by the International Diabetes Federation consensus was investigated in the Japanese general population. Factors associated with ClinPN and NCA were also identified.

Materials And Methods: A total of 625 examinees of regional medical checkup programs were recruited to this cross-sectional study. ClinPNs were diagnosed by the Toronto Consensus. NCA was judged by at least one bilateral abnormality of sural nerve action potential amplitude or conduction velocity measured by a point-of-care nerve conduction device (DPNCheck). Clinical factors associated with ClinPNs or NCA were examined by multiple logistic regression analysis. Deteriorating factors of sural nerve action potential amplitude or conduction velocity values were also investigated in participants without diabetes (n = 550).

Results: As for glucose tolerance, ClinPNs or NCA significantly increased only in known diabetes patients compared with other groups. There was no difference between prediabetes and the normal group. The prevalence of ClinPNs and NCA was not significantly related to MetS or MetS' components, except for frequent NCA in obesity. The factors significantly associated with both NCA and ClinPNs were smoking and known diabetes. In non-diabetic participants, aging, tall height and hypertension were significant deteriorating factors of nerve conduction functions.

Conclusions: In Japan, ClinPNs and NCA were increased in known diabetes patients, but did not increase in participants with prediabetes, MetS and MetS' components. Smoking and known diabetes were factors significantly associated with ClinPNs or NCA. Hypertension might be a modifiable deteriorating factor of nerve function.

Citing Articles

Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy.

Wu Y, Wan Q, Xu Y, Li J, Li K, Zhang Z Diabetes Metab Syndr Obes. 2022; 15:3639-3654.

PMID: 36439295 PMC: 9694982. DOI: 10.2147/DMSO.S388330.

Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments.

Elafros M, Andersen H, Bennett D, Savelieff M, Viswanathan V, Callaghan B Lancet Neurol. 2022; 21(10):922-936.

PMID: 36115364 PMC: 10112836. DOI: 10.1016/S1474-4422(22)00188-0.

[The role of glycation end products in the development and progression of diabetic neuroarthropathy].

Kalandiya M, Tokmakova A, Galstyan G Probl Endokrinol (Mosk). 2021; 67(3):4-9.

PMID: 34297497 PMC: 9112848. DOI: 10.14341/probl12778.

Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.

Kirthi V, Perumbalath A, Brown E, Nevitt S, Petropoulos I, Burgess J BMJ Open Diabetes Res Care. 2021; 9(1).

PMID: 34006607 PMC: 8137250. DOI: 10.1136/bmjdrc-2020-002040.

Bilateral atrophy of the extensor digitorum brevis muscle might be a useful sign for diagnosing diabetic polyneuropathy in Japanese men who do not sit in the traditional "seiza" style.

Kishimoto S, Sasaki H, Kurisu S, Ogawa K, Matsuno S, Furuta H J Diabetes Investig. 2021; 12(3):398-408.

PMID: 33481342 PMC: 7926247. DOI: 10.1111/jdi.13367.

References

Im S, Kim S, Park J, Kim Y, Park G . Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses. Diabetes Care. 2011; 35(4):834-9. PMC: 3308311. DOI: 10.2337/dc11-1001. View

Bongaerts B, Rathmann W, Heier M, Kowall B, Herder C, Stockl D . Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study. Diabetes Care. 2013; 36(5):1141-6. PMC: 3631873. DOI: 10.2337/dc12-0744. View

Hirayasu K, Sasaki H, Kishimoto S, Kurisu S, Noda K, Ogawa K . Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck™). J Diabetes Investig. 2018; 9(5):1173-1181. PMC: 6123044. DOI: 10.1111/jdi.12818. View

Trojaborg W, Moon A, Andersen B, Trojaborg N . Sural nerve conduction parameters in normal subjects related to age, gender, temperature, and height: a reappraisal. Muscle Nerve. 1992; 15(6):666-71. DOI: 10.1002/mus.880150606. View

Matsuno S, Sasaki H, Yamasaki H, Yamaoka H, Ogawa K, Nakatani M . Pro198Leu missense polymorphism of the glutathione peroxidase 1 gene might be a common genetic predisposition of distal symmetric polyneuropathy and macrovascular disease in Japanese type 2 diabetic patients. J Diabetes Investig. 2014; 2(6):474-82. PMC: 4014907. DOI: 10.1111/j.2040-1124.2011.00127.x. View

Dyck P, Clark V, Overland C, Davies J, Pach J, Dyck P . Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care. 2012; 35(3):584-91. PMC: 3322692. DOI: 10.2337/dc11-1421. View

Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A . Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2007; 31(3):464-9. DOI: 10.2337/dc07-1796. View

Lee C, Perkins B, Kayaniyil S, Harris S, Retnakaran R, Gerstein H . Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort. Diabetes Care. 2015; 38(5):793-800. DOI: 10.2337/dc14-2585. View

Asghar O, Petropoulos I, Alam U, Jones W, Jeziorska M, Marshall A . Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care. 2014; 37(9):2643-6. PMC: 4140158. DOI: 10.2337/dc14-0279. View

10.

Andersen S, Witte D, Andersen H, Bjerg L, Bruun N, Jorgensen M . Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care. 2018; 41(9):1955-1962. DOI: 10.2337/dc18-0392. View

11.

Visser N, Vrancken A, van der Schouw Y, van den Berg L, Notermans N . Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. Diabetes Care. 2012; 36(4):817-22. PMC: 3609524. DOI: 10.2337/dc12-0469. View

12.

Divisova S, Vlckova E, Hnojcikova M, Skorna M, Nemec M, Dubovy P . Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres. J Peripher Nerv Syst. 2012; 17(3):341-50. DOI: 10.1111/j.1529-8027.2012.00420.x. View

13.

Hanewinckel R, van Oijen M, Ikram M, van Doorn P . The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2015; 31(1):5-20. PMC: 4756033. DOI: 10.1007/s10654-015-0094-6. View

14.

Singleton J, Smith A, Bromberg M . Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001; 24(8):1448-53. DOI: 10.2337/diacare.24.8.1448. View

15.

Callaghan B, Xia R, Banerjee M, de Rekeneire N, Harris T, Newman A . Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status. Diabetes Care. 2016; 39(5):801-7. PMC: 4839175. DOI: 10.2337/dc16-0081. View

16.

Clair C, Cohen M, Eichler F, Selby K, Rigotti N . The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. J Gen Intern Med. 2015; 30(8):1193-203. PMC: 4510224. DOI: 10.1007/s11606-015-3354-y. View

17.

Kurisu S, Sasaki H, Kishimoto S, Hirayasu K, Ogawa K, Matsuno S . Clinical polyneuropathy does not increase with prediabetes or metabolic syndrome in the Japanese general population. J Diabetes Investig. 2019; 10(6):1565-1575. PMC: 6825938. DOI: 10.1111/jdi.13058. View

18.

Tesfaye S, Chaturvedi N, Eaton S, Ward J, Manes C, Ionescu-Tirgoviste C . Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005; 352(4):341-50. DOI: 10.1056/NEJMoa032782. View

19.

Green A, Krishnan S, Finucane F, Rayman G . Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care. 2009; 33(1):174-6. PMC: 2797968. DOI: 10.2337/dc09-0101. View

20.

Pop-Busui R, Boulton A, Feldman E, Bril V, Freeman R, Malik R . Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2016; 40(1):136-154. PMC: 6977405. DOI: 10.2337/dc16-2042. View